Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine Source: Eur Respir J 2002; 19: 611-616 Year: 2002
Effect of an inhaled adenosine A2A agonist on the allergen induced late asthmatic response Source: Eur Respir J 2003; 22: Suppl. 45, 204s Year: 2003
PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Effects of histamine and leukotriene antagonism on mannitol and adenosine monophosphate (AMP) challenge Source: Eur Respir J 2002; 20: Suppl. 38, 386s Year: 2002
Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis Source: Eur Respir J 2001; 17: 64-70 Year: 2001
The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004
Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
Inhaled corticosteroids and leukotriene receptor antagonists induce protection against adenosine 5‘monophosphate induced bronchospasm in a synergic fashion Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Association between atopic status and airway reactivity to methacholine and adenosine monophosphate Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
Effect of airway provocation with histamine and adenosine 5’-monophosphate on sputum neutrophils and -related mediators Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Direct and indirect bronchial challenge tests with Methacholine and Adenosine monophosphate in asthmatic patients and healthy subjects Source: Annual Congress 2010 - Advances in lung function II Year: 2010
Unraveling adenosine and AMP induced dyspnea sensation in asthma Source: International Congress 2018 – Tests and trends in asthma Year: 2018
Late asthmatic response is modulated by TRPA1 antagonists in ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012
Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D4 challenge in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002
Extracellular and intracellular magnesium before and after methacholine-induced bronchoconstriction in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 504s Year: 2002
Increased airway responsiveness to beta-adrenergic agonists in asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005
Protection by formoterol and salmeterol on bronchoconstriction provoked by methacholine and AMP in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 307s Year: 2002
An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) Source: International Congress 2017 – Monitoring asthma control Year: 2017
Prostaglandin D2 (PGD2 ) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006